How to Choose a Longevity Clinic: A 100-Point Evidence and Follow-Up Scorecard
A provider-neutral 100-point scorecard for evaluating licensing, evidence, diagnostics, follow-up, pricing and records before paying a longevity clinic.
Choosing a longevity clinic should not depend on the number of tests, futuristic language or a site ranking. Use the scorecard below to compare providers from documents they can produce before payment.
The academic paper used as this article’s starting point proposes a framework for longevity clinics, but it also says there is no universally accepted standard model.1 It is a review and proposed framework, not a clinical guideline or certification scheme.
This WLC scorecard is an editorial due-diligence tool. It does not rate medical outcomes and does not replace advice from a clinician who knows your history.
Five Automatic Stop Rules
Do not use the numerical score to excuse any of these:
- no named clinician or verifiable license for medical care;
- guaranteed lifespan, age reversal or disease-prevention claims;
- no process for urgent or incidental findings;
- pressure to buy peptides, hormones, biologics or IVs before assessment;
- an unapproved regenerative product sold as routine care without a lawful trial or other documented pathway.
If a stop rule applies, pause the purchase until it is resolved in writing.
The 100-Point Scorecard
| Domain | Points | Evidence to request |
|---|---|---|
| Licensing, governance and safety | 20 | Legal provider, responsible clinician, license, emergency and adverse-event process |
| Evidence and claim discipline | 20 | Evidence by intervention, regulatory status, limits and alternatives |
| Diagnostic appropriateness | 15 | Test-by-test rationale, eligibility, false-positive and confirmation plan |
| Interpretation and follow-up | 20 | Named owner, prioritized report, referrals, retesting and local-doctor coordination |
| Price and conflicts | 15 | Itemized quote, add-ons, commissions, claimed/sponsored relationships |
| Records and outcome measurement | 10 | Raw data, exportable report, baseline, targets and longitudinal review |
| Total | 100 |
Score only what is documented. A sales promise without a written policy earns zero.
1. Licensing, Governance and Safety: 20 Points
Award:
- 5 points for the legal entity delivering medical care;
- 5 points for a named responsible clinician with a verifiable license;
- 5 points for an emergency and adverse-event pathway;
- 5 points for clear consent, privacy and complaint processes.
A hotel, spa or wellness brand is not automatically the medical provider. Ask which entity orders tests, prescribes treatment and owns the medical record.
For a country-by-country overview, use our longevity clinic regulation guide.
2. Evidence and Claim Discipline: 20 Points
Award:
- 5 points if every intervention has a defined purpose and eligible patient;
- 5 points if approval, off-label, experimental or wellness status is explicit;
- 5 points if human evidence and important limitations are explained;
- 5 points if alternatives, risks and contraindications appear before purchase.
The strongest signals are often boring: blood-pressure management, established screening, exercise, sleep, nutrition and metabolic risk reduction. A provider can offer experimental care, but it must not turn animal data, mechanisms or testimonials into proof of human benefit.
The FDA warns that many regenerative products marketed to consumers, including some stem-cell and exosome products, are unapproved and may require oversight in a clinical trial.2
3. Diagnostic Appropriateness: 15 Points
Award:
- 5 points for a reason each test is appropriate to age, history or risk;
- 5 points for a false-positive and incidental-finding policy;
- 5 points for a confirmation and referral plan.
More testing increases the opportunity to find abnormalities, including uncertain ones. The American College of Radiology says evidence is insufficient to recommend total-body screening MRI for asymptomatic people without relevant risk factors or family history.3
Ask one question for every test: What decision changes because of this result?
4. Interpretation and Follow-Up: 20 Points
Award:
- 5 points for physician-led interpretation;
- 5 points for a prioritized plan rather than a data dump;
- 5 points for named responsibility after abnormal findings;
- 5 points for scheduled follow-up and retesting.
A clinic visit is incomplete if the output is a dashboard and instructions to find another doctor. Confirm who handles referrals, medication decisions, urgent findings and coordination with your existing clinicians.
Use our follow-up plan checklist to review the proposed care loop.
5. Price and Conflicts: 15 Points
Award:
- 5 points for an itemized quote;
- 5 points for written add-on, renewal and cancellation terms;
- 5 points for disclosure of financial, referral, sponsorship or directory relationships.
Separate:
- diagnostics;
- physician time;
- treatments and supplements;
- accommodation and hospitality;
- follow-up and retesting.
Do not infer value from a package total. A lower-cost assessment without clinical ownership can be worse value than a narrower program with clear follow-up.
6. Records and Outcome Measurement: 10 Points
Award:
- 5 points for raw results and an exportable clinician report;
- 5 points for baseline measures, targets and a schedule to reassess them.
Biological-age scores and proprietary dashboards should not be the only record. You should be able to share useful results with another licensed clinician.
How to Interpret the Score
| Score | Editorial interpretation | Next action |
|---|---|---|
| 80 to 100 | Strong documentation | Shortlist, then verify clinical fit |
| 60 to 79 | Material questions remain | Request missing evidence before paying |
| Below 60 | Weak accountability or transparency | Do not book until major gaps are resolved |
An automatic stop rule overrides the total. The score is not a medical-quality certification and should not be published as a patient-outcome ranking.
Copy-and-Send Request
Send this before a sales call:
Please provide the legal medical provider, responsible clinician and license jurisdiction; the full program schedule and itemized price; every included test and intervention; approval or experimental status; contraindication and adverse-event process; who handles abnormal findings; follow-up schedule; and the records I will receive. Please separate medical services from accommodation and optional add-ons.
Compare written responses, not sales-call confidence.
Why This Scorecard Is Different From a Clinic Ranking
A ranking usually compresses many assumptions into one number. This scorecard keeps the evidence visible:
- it does not reward a longer treatment menu;
- it does not treat provider marketing as an outcome;
- it does not award points for luxury or celebrity clients;
- it penalizes missing follow-up and conflicts;
- it allows another reader to reproduce the result.
The critical editorial review “Longevity clinics: between promise and peril” describes both the preventive potential of the model and risks from high cost, unproven interventions, inconsistent standards and commercial incentives.4 A useful selection process must test both sides.
Bottom Line
Choose the clinic that can document who is responsible, why each test or intervention is appropriate, what happens after an abnormal result and what the complete relationship will cost.
Do not choose from vocabulary, treatment count or a proprietary score. A defensible clinic decision should survive the same written checklist even when the brand name is removed.
Medical note: this scorecard is educational. Symptoms, known disease and urgent concerns belong with appropriate medical care, not a wellness sales process.
Editorial disclosure: WLC operates a clinic directory. Claimed, sponsored or listed status does not change the scoring rules in this article.
Footnotes
-
Mironov et al., “A Framework for an Effective Healthy Longevity Clinic”, Aging and Disease, 2025. ↩
-
U.S. Food and Drug Administration, consumer information about regenerative medicine therapies, accessed August 28, 2026. ↩
-
American College of Radiology, statement on screening total-body MRI, accessed August 28, 2026. ↩
-
Marco Demaria, “Longevity clinics: between promise and peril”, Aging, 2025. ↩